Hemophilia Market Size Is Projected To Grow At A CAGR Of 5.6% From 2016 to 2024: Grand View Research, Inc.

Aug 25, 2016

According to report published by Grand View Research, Inc., global hemophilia market will reach $15.2 billion by 2024, Increasing need for diagnosis of the target population in order to initiate prophylaxis treatment and supportive government programs is expected to be vital impact rendering driver.

San Francisco, California, United States - August 25, 2016 /MarketersMedia/ —

Global hemophilia market is expected to reach USD 15.2 billion by 2024, according to a new report by Grand View Research, Inc. Increasing need for diagnosis of the target population in order to initiate prophylaxis treatment and supportive government programs is expected to be the vital impact rendering driver.
The market players are predicted to adopt strategies such as pipeline product development and geographic expansion in underdeveloped and developing regions, such as Middle Eastern and West African countries.
As of 2015, federal bodies such as the World Federation Hemophilia have vast information and treatment regulation in about 172 countries, of which 20 were added in 2013,including Nigeria, Togo, Mali, Zambia, Mauritania, and others.
Competitive pricing strategy is a vital factor promoting market players’ growth over the forecast period. For instance, Biogen launched Eloctate in 2014 in the U.S. at a lower price than the existing vastly used drug Advate.

Access full research report: http://www.grandviewresearch.com/industry-analysis/hemophilia-treatment-industry

Key findings

• Hemophilia B is expected to grow at a rapid rate of over 6.0% during the forecast period. Higher emphasis on pipeline products with an extended half-life and increasing incidence of hemophilia B affected patients are expected to be the prominent growth factors.
• On-demand treatment dominated the segment over the forecast period and is expected to contribute more than 50.0% by 2024. However, prophylaxis is expected to be the fastest growing segment because of the requirement for better control of bleeding episodes and growing financial assistance programs by healthcare providers and industry players.
• For instance, Grifols has launched the “AlphaNine SD Copay Card” and “ALPHANATE Copay Program” for immediate enrollment in prophylaxis treatment by patients.
• On the basis of therapy, gene therapy is expected to be the fastest growing segment as a result of increasing R&D and innovations in the field. Furthermore, replacement therapy is expected to witness lucrative growth due to the launch of extended half-life versions of currently available drugs.
• For instance, Novo Nordisk is working on N8-GP, CSL Behring is working on CSL689 rVIIa-FP, and Bayer is working on BAY 94-9027.These are expected to be commercially available around 2017/2018. This is expected to improve treatment over the forecast period thereby boosting growth.
• Major market players include Biogen, Novo Nordisk, Baxalta, Octapharma, CSL Behring, Pfizer, Inc., and Bayer Healthcare. Most of the companies are actively involved in the awareness and treatment programs launched by regional governments and hemophilia associations. Majority of their products that are awaiting FDA approval have extended therapeutic use in adults as well as children.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/pharmaceuticals

Market Segments:

Global Hemophilia Market by Type (USD Million), 2013 – 2024
• Hemophilia A
• Hemophilia B
• Hemophilia C
• Others
Global Hemophilia Market by Treatment (USD Million), 2013 – 2024
• On-demand
• Prophylaxis
Global Hemophilia Market Therapy(USD Million), 2013 – 2024
• Replacement Therapy
• Immune Tolerance Induction Therapy
• Gene Therapy
Hemophilia Market By Region (USD Million), 2013 – 2024
• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia-Pacific
• Japan
• China
• Latin America
• Brazil
• Mexico
• Middle East and Africa
• South Africa
• Saudi Arabia

Access press release of this research report: http://www.grandviewresearch.com/press-release/global-hemophilia-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services.

For more information, please visit http://www.grandviewresearch.com/industry-analysis/hemophilia-treatment-industry

Contact Info:
Name: Sherry James
Email: [email protected]
Organization: Grand View Research, Inc.
Address: 28 2nd Street, Suite 3036, San Francisco, California, 94105
Phone: 1-415-349-0058

Source: http://marketersmedia.com/hemophilia-market-size-is-projected-to-grow-at-a-cagr-of-5-6-from-2016-to-2024-grand-view-research-inc/129502

Release ID: 129502

More News

Body and soul, between heaven and earth

Oct 27, 2026

Body and soul, between heaven and earth

All Souls’ Day could possibly be more than its traditional concept. We hope that we touch the people we cherish through prayer — somewhere far away. And we visit them where they have left their bodies. We bring flowers to where their bodies rest. And in silence and gratitude, we pause while reminiscing about our shared memories. Two in one But what if the body is in the soul and yet the soul is inside the body? You see, those who have had near-death experiences, those very souls who have stood between the heavenly and earthly realms, tell us it is so. Those who were in life-and-death situations leave their bodies and yet feel they are more embodied than ever. They are overcome with a lightness of being, moving at a speed that is faster than light. They have a glimpse of pure freedom and joy. They see the hospital room and their bodies from above and feel no pain. They are given an instant sense of clarity that their body was living inside a much larger field. And at the same time, they feel their soul was always inside their body — tucked into every breath. A relative who survived a near-fatal heart attack told me, “I was not inside my body. My body was inside me.” A contradiction, perhaps. But it was his truth. Our soul is inside the body. That is why a cut can make you feel bad and why sickness can cause one to feel helpless. This is also the reason why a hand held in yours is not only comforting to the touch but also stirs something much deeper inside of you. It is love, something unseen that touches the spirit. And your body is inside your soul. This is why, when you love someone, you feel larger than life. And why, when you grieve, you do not seem to fit inside your body of skin. It is clear that body and soul are interconnected. Beyond walking There are two kinds of walking. Walking with the body — muscle, heart, bone. You count your strides and sweat all the way up to 3,000 steps. The body needs to be trained to endure in order to get stronger. And there is walking with the soul — when you walk long enough that your mind becomes still, unmuddled by everyday stress. Your feet find a familiar rhythm. Your breath deepens. This is when your soul catches up and walks with you. You see, the first walk burns calories, while the second walk burns the illusion that you are alone. People who return from the threshold are made to go back. Their mission isn’t over. They never talk about it as a dimension that is far away. They know it as some place close by. It is the very breath inside you — and you inside the breath. On All Souls’ Day, try to walk both walks. Walk with your body to the cemetery. And keep walking with your soul. Walk until you feel that you have never left your dearly departed loved ones. Nor have they left you. You are still inside their love. And they are still inside you. Between here and the hereafter, there is not a wall. There is a path. And we are all walking it — body and soul. Affirmation: “Heaven is within me.” Luke 17:21, KJV: “The kingdom of God is within you.” Love and light.

UK hydration brand enters Asia through Philippine market

Oct 27, 2026

UK hydration brand enters Asia through Philippine market

UK hydration brand Vidrate has entered the Asian market through the Philippines, marking its first expansion into the region in partnership with CTC Group Philippines. The launch was celebrated at “Get Vidrated,” an event held at the Pool House of Grand Hyatt Manila that featured yoga, sound healing, recovery stations and product demonstrations. Sarah Hulton, British Ambassador to the Philippines and Palau, attended the event and highlighted the United Kingdom’s strengths in health, science and consumer-product innovation. She noted that British businesses and entrepreneurs are developing products that help people lead healthier, more active lives. Hulton described Vidrate’s Philippine launch as an example of British innovation meeting Philippine entrepreneurship and market expertise. She also underscored the growing commercial relationship between the two countries and encouraged local retailers, distributors, wellness advocates and fitness businesses to explore opportunities with the brand. Founded by Nick Hird and Rob Bennett, Vidrate produces powdered hydration products in sachets that combine flavor, electrolytes, fiber and added vitamins. Its Everyday Hydration range contains zero sugar, natural ingredients and added vitamins C and B12. The company was ranked 28th nationally in “The Sunday Times 100” 2026, which recognizes the United Kingdom’s fastest-growing private companies. Its entry into the Philippines marks a step in its international expansion, with co-founder Hird looking to introduce the brand’s everyday hydration products to consumers in new markets. For CTC Group Philippines, the launch reflects its work in helping international brands establish a presence in the local market. The international business group operates in 12 countries, with a strong focus on life sciences, and supports companies through market expertise, regulatory awareness, strategic partnerships and local execution. CTC Group said it prioritizes responsible commercialization by assessing scientific evidence, substantiating product claims and complying with Philippine Food and Drug Administration requirements and other applicable regulatory standards. The company also considers whether products address relevant consumer and community needs, beyond their commercial potential. As the group continues to work with international companies across its network, its stated focus remains on connecting global innovation with local markets through scientific credibility, regulatory responsibility and strategic brand development.

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.